8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 28, 2007

Sontra Medical Corporation

(Exact name of registrant as specified in its charter)

Minnesota (State or Other Jurisdiction of Incorporation)	000-23017 (Commission File Number)	41-1649949 (I.R.S. Employer Identification No.)
10 Forge Parkway Franklin, Massachusetts		02038
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (508) 553-8850

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     Effective October 8, 2007, Sontra Medical Corporation (the “Company”) amended its Second Amended and Restated Articles of Incorporation, as amended, to change the name of the Company to “Echo Therapeutics, Inc.”.

Item 9.01. Financial Statements and Exhibits

(d)      Exhibits.

Exhibit No.	Description
3.1	Articles of Amendment of Second Amended and Restated Articles of Incorporation, as amended, of Sontra Medical Corporation filed with the Secretary of State of the State of Minnesota on September 28, 2007 and effective October 8, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	SONTRA MEDICAL CORPORATION
Dated: October 3, 2007	By:	/s/ Harry G. Mitchell
		Name:	Harry G. Mitchell
		Title:	Chief Operating Officer and Chief Financial Officer

EXHIBIT INDEX

Exhibit No.	Description
3.1	Articles of Amendment of Second Amended and Restated Articles of Incorporation, as amended, of Sontra Medical Corporation filed with the Secretary of State of the State of Minnesota on September 28, 2007 and effective October 8, 2007.

EX-3.1

Exhibit 3.1

ARTICLES OF AMENDMENT OF
OF
SECOND AMENDED AND RESTATED
ARTICLES OF INCORPORATION, AS AMENDED,
OF
SONTRA MEDICAL CORPORATION

     The undersigned, being the Chief Executive Officer of Sontra Medical Corporation, a Minnesota corporation (the “Corporation”) does hereby certify that pursuant to the provisions of Chapter 302A of the Minnesota Business Corporation Act, including Section 302A.135 thereof, the following amendment to the Second Amended and Restated Articles of Incorporation, as amended, of the Corporation was duly adopted by unanimous written consent to action without a meeting of the Board of Directors:

     RESOLVED, that the Second Amended and Restated Articles of Incorporation of the Corporation are hereby amended by striking out ARTICLE 1 thereof in its entirety and by substituting in lieu of said ARTICLE 1 the following new ARTICLE 1:

           “ARTICLE 1. The name of the Corporation is Echo Therapeutics, Inc.”

     The undersigned swears that the foregoing is true and accurate and that the undersigned has the authority to sign this document on behalf of the Corporation. The foregoing Articles of Amendment shall be effective as of October 8, 2007.

SONTRA MEDICAL CORPORATION
By:	/s/ Patrick T. Mooney
Name:		Patrick T. Mooney
Title:		Chief Executive Officer